Aclarion, Inc.ACON

$3.12+0.01 (+0.32%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$7M
Micro-cap
-66%
2022 — today
10-Year Price
-100%
2022 — today
52-Week Range
$2.36$9.69
Current $3.12· 10%

Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.

Valuation in context

P/E ratio
-0.3
N/A
Not meaningful — company is unprofitable
P/B ratio
0.3
Above average
Pricier than usual over the last 10 years
FCF Yield
-110.5%
Above average
Above the 10-year average
Free · No credit card needed

Get alerted when ACON is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.